BrainStorm's ALS therapy not effective, FDA panel finds
BioPharma
Stay updated with breaking news from Jan Nolta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orgenesis and University of California, Davis sign partnership agreement for rollout of cell and gene therapy mobile processing units and labs throughout California Germantown, Maryland and Davis, California, US, June 7, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company&r...
The University of California, Davis, announced the recipients of the 2022 Chancellor’s Innovation Awards at an in-person event on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in our global society.
An immunotherapy treatment for blood cancers has sent one local patient into complete remission, and may eventually lead to breakthroughs.
Hematopoiesis in patients with acute myeloid leukemia could potentially be improved by blocking transforming growth factor beta 1 (TGFβ1).